Skip to contentE
Endovia Health Sciences, Inc.
E
EDVAEndovia Health Sciences, Inc. Q1 2016 · 10-Q
Revenue$259.65K$259.65K+22.5% vs Q1 2015 Net Income$12.08K$12.08KN/M vs Q1 2015 EPS Diluted$0.00$0.00— vs Q1 2015 Gross Profit$133,343+11.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endovia Health Sciences, Inc. · CIK 1553788 · Engraved from SEC EDGAR
Operating Cash Flow$49,325N/M Free Cash Flowderived$29,627N/M Margins · derivedGross margin51.4%−5.2 pt vs Q1 2015
Operating margin4.5%+4.4 pt vs Q1 2015
Net margin4.7%+5.1 pt vs Q1 2015
ended Mar 31, 2016 · filed Nov 15, 2016 · 229 d after period end